•
Sep 30, 2016

Corcept Therapeutics Q3 2016 Earnings Report

Total Revenue
$21.7M
Previous year: $13.3M
+63.8%
EPS
$0.04
Previous year: -$0.01
-500.0%
Gross Profit
$21.1M
Cash and Equivalents
$47.9M
Total Assets
$62.9M

Corcept Therapeutics

Corcept Therapeutics